GlassScriptPhysician profile
Christopher M Sakowski
NPI 1003255415
$107,026.68
in general payments reported to CMS, 2019-2025
19 companies · $1,891 in 2025
The $1,891 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $37K · 2021: $20K · 2022: $5,112 · 2023: $2,102 · 2024: $9,088 · 2025: $1,891.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,745 · Travel and Lodging: $3,030 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,935 · Food and Beverage: $2,370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,745.00 |
| Travel and Lodging | $3,030.38 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,935.00 |
| Food and Beverage | $2,370.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Orthopaedic Solutions, INC. | $63,672.62 | 2019-2020 | |
| Arthrex, INC. | $37,007.52 | 2019-2025 | Arthrex, Distal Extremities Implants Trauma |
| Pylant Medical | $4,564.66 | 2019-2025 | |
| Stryker Corporation | $550.73 | 2021-2025 | Axs Infinity Ls, Biofoam, Citrefix |
| Restor3d, INC. | $305.39 | 2022-2023 | |
| Ferring Pharmaceuticals INC. | $153.39 | 2019-2025 | Euflexxa |
| Integra Lifesciences Corporation | $145.09 | 2019-2020 | |
| Depuy Synthes Sales INC. | $130.27 | 2021-2025 | Orthovisc, Monovisc |
| Smith+Nephew, INC. | $110.37 | 2019-2024 | N/A, Renasys Touch |
| Bioventus LLC | $105.91 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Medline Industries LP | $69.16 | 2021-2024 | |
| Extremity Medical | $56.56 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $36.78 | 2025 | |
| Next Science LLC | $26.73 | 2023 | Surgx, Blastx, Xperience |
| Axogen | $25.28 | 2023 | Avance Nerve Graft |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $18.07 | 2022 | |
| Wright Medical Technology, INC. | $17.29 | 2019 | |
| Merck Sharp & Dohme LLC | $16.08 | 2022 | |
| Kerecis Limited | $14.78 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Sakowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.